C4 Therapeutics
CCCC
#7905
Rank
S$0.33 B
Marketcap
$4.78
Share price
-5.05%
Change (1 day)
-47.23%
Change (1 year)

Revenue for C4 Therapeutics (CCCC)

Revenue in 2024 (TTM): S$44.36 Million

According to C4 Therapeutics's latest financial reports the company's current revenue (TTM ) is S$46.26 Million. In 2023 the company made a revenue of S$27.41 Million a decrease over the revenue in the year 2022 that were of S$41.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for C4 Therapeutics from 2020 to 2024

202120222023$30M$40M$50M$60M$70Mcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) S$44.36 M61.85%
2023 S$27.41 M-34.24%
2022 S$41.68 M-32.65%
2021 S$61.89 M40.95%
2020 S$43.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA